Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements
Griffen E, Boulet P, Albrecht R, Akbar A, Amick I, Aschenbrenner J, Balcomb B, Barr H, Battu H, Benjamin J, Bloom J, Boby M, Bogyo M, Bolon D, Boulet P, Clerkin A, Cadagan R, Capkin E, Castellanos M, Chandran A, Chen S, Chodera J, Cole D, Cousins D, Cuadrado S, de Godoy A, Dhalech A, Diaz R, DiPoto M, Doherty J, Dotson D, Duggan S, Evans M, Fairhead M, Fate G, Fearon D, Federov O, Ferla M, Ferreira L, Fieseler K, Filep M, Flores D, Flynn J, Fraisse L, Ronen G, Gad B, Garcia-Sastre A, Gathecha C, Gayvert J, Giroud C, Parejo C, Goldberger E, Golding M, Gordon M, Griffen E, Hannon W, Hassan H, Henry M, Hertzman R, Horton J, Huang F, Huang Q, Iacovella C, Isaacs F, James D, Jameson M, Kaminow B, Kenney I, Kenton N, Kirkegaard K, Koekemoer L, Kurtyilmaz N, La V, Lahav N, Lambert M, Lavie M, Lee A, Lefker B, Lemons K, Lindenbach B, Lithgo R, Livnah E, London N, Lynch N, MacDermott H, MacLean E, Marples P, Marsden B, McGovern B, Minh D, Mugeni M, Nadir A, Luong N, Ni X, Nitz S, Ookhin H, Orlov A, Payne A, Pearl R, Pedowitz N, Peng S, Perry B, Pulido I, Rawal D, Reid L, Retchin M, Richardson R, Ripka E, Robinson M, Robinson R, Rodriguez M, Roper G, Rosales R, Salim M, Scheen J, Schiffer C, Shamir Y, Shaqra A, Shaw C, Shertzer O, Singh S, Sjo P, Slater J, Souffront A, Stacey J, Gordon H, Starr T, Stewart H, Szommer T, Tanner W, Thomas V, Thompson W, Tierney J, Tivon B, Tomlinson C, Vargo T, Villalo F, von Delft A, von Delft F, Walsh M, Sije W, Wang S, Wang Y, Waring M, White K, Wild C, Wilen C, Williams E, Williams M, Winokan M, Wright N, Xavier M, Yap J, Zhang I, Zhu J, Zwaka T, Robinson M, London N, Resnick E, Zaidmann D, Gehrtz P, Reddi R, Gabizon R, Barr H, Duberstein S, Zidane H, Shurrush K, Cohen G, Solmesky L, Lee A, Jajack A, Cvitkovic M, Pan J, Pai R, Ripka E, Nguyen L, Shafeev M, Matviiuk T, Michurin O, Chernyshenko E, Bilenko V, Kinakh S, Logvinenko I, Melnykov K, Huliak V, Tsurupa I, Gorichko M, Shaikh A, Pinjari J, Swamy V, Pingle M, BVNBS S, Aimon A, von Delft F, Fearon D, Tomlinson C, Balcomb B, Lithgo R, Aschenbrenner J, Dunnett L, Douangamath A, Dias A, Powell A, Neto J, Skyner R, Thompson W, Gorrie-Stone T, Walsh M, Owen C, Lukacik P, Strain-Damerell C, Mikolajek H, Horrell S, Marples P, Koekemoer L, Krojer T, Fairhead M, MacLean E, Thompson A, Wild C, Smilova M, Wright N, von Delft A, Gileadi C, Rangel V, Schofield C, Salah E, Malla T, Tumber A, John T, Vakonakis I, Kantsadi A, Zitzmann N, Brun J, Kiappes J, Hill M, Witt K, Alonzi D, Makower L, Varghese F, Overheul G, Miesen P, van Rij R, Jansen J, Smeets B, TomĂĄsio S, Weatherall C, Vaschetto M, Macdonald H, Chodera J, Rufa D, Wittmann M, Boby M, Henry M, Glass W, Eastman P, Coffland J, Dotson D, Griffen E, McCorkindale W, Morris A, Glen R, Cole J, Foster R, Foster H, Calmiano M, Tennant R, Heer J, Shi J, Jnoff E, Hurley M, Lefker B, Robinson R, Giroud C, Bennett J, Fedorov O, Reid P, Morwitzer M, Cox L, Morris G, Ferla M, Moustakas D, Dudgeon T, PĆĄenĂĄk V, Kovar B, Voelz V, Carbery A, Contini A, Clyde A, Ben-Shmuel A, Sittner A, Politi B, Vitner E, David E, Tamir H, Achdout H, Levy H, Glinert I, Paran N, Erez N, Puni R, Melamed S, Weiss S, Israely T, Yahalom-Ronen Y, Smalley A, Oleinikovas V, Spencer J, Kenny P, Ward W, Cattermole E, Ferrins L, Eyermann C, Milne B, Godoy A, Noske G, Oliva G, Fernandes R, Nakamura A, Gawriljuk V, White K, McGovern B, Rosales R, GarcĂa-Sastre A, Carney D, Chang E, Saikatendu K, Vangeel L, Neyts J, Donckers K, Jochmans D, De Jonghe S, Bowman G, Borden B, Singh S, Volkamer A, Rodriguez-Guerra J, Fate G, Hart S, Saar K, Perry B, Fraisse L, Sjö P, Boulet P, Laghnimi-Hahn S, Mowbray C, Reid L, Rees P, Huang Q, Zvornicanin S, Shaqra A, Yilmaz N, Schiffer C, Zhang I, Pulido I, Taylor J, Croll T, Brewitz L, Kang L, La V, Haneef A, Minh D, Filep M, Scheen J, Kaminow B, Arbon R, Payne A, Schaller D. Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements. Wellcome Open Research 2024, 9: 374. PMID: 39184131, PMCID: PMC11342024, DOI: 10.12688/wellcomeopenres.22645.1.Peer-Reviewed Original ResearchIntellectual propertyContractual agreementsIntellectual property agreementsGlobal intellectual propertyEquitable accessIP policyPatent protectionIP frameworkEffective global responsePandemic preparednessGlobal frameworkMarket forcesCOVID-19 pandemicAgreementGlobal responseObligationsRightsOpen science approachOpen scienceNegotiationProtectionScience approachCOVID-19AccessPandemic
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply